VIENNA, Oct 27 (Reuters) - Austrian biotech firm Intercell (ICEL.VI: Quote, Profile, Research) will provide U.S. drug maker Merck & Co (MRK.N: Quote, Profile, Research) with technology for a vaccine against streptococcus infections, expanding its cooperation with Merck.
